<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-15T15:07:51Z</responseDate><request verb="GetRecord" identifier="oai:gredos.usal.es:10366/155372" metadataPrefix="rdf">https://gredos.usal.es/oai/request</request><GetRecord><record><header><identifier>oai:gredos.usal.es:10366/155372</identifier><datestamp>2025-04-30T19:28:39Z</datestamp><setSpec>com_10366_3974</setSpec><setSpec>com_10366_3947</setSpec><setSpec>com_10366_3946</setSpec><setSpec>com_10366_3823</setSpec><setSpec>col_10366_3975</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
<ow:Publication rdf:about="oai:gredos.usal.es:10366/155372">
<dc:title>Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study</dc:title>
<dc:creator>COVIDSurgCollaborative</dc:creator>
<dc:creator>GlobalSurgCollaborative</dc:creator>
<dc:subject>COVID-19;</dc:subject>
<dc:subject>delay;</dc:subject>
<dc:subject>SARS-CoV-2;</dc:subject>
<dc:subject>surgery;</dc:subject>
<dc:subject>timing</dc:subject>
<dc:description>[EN]Peri-operative SARS-CoV-2 infection increases postoperative mortality. The aim of this study was to determinethe optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. Thisinternational, multicentre, prospective cohort study included patients undergoing elective or emergencysurgery during October 2020. Surgical patients with pre-operative SARS-CoV-2 infection were compared withthose without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperativemortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by timefrom diagnosis of SARS-CoV-2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients(2.2%) had a pre-operative SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2infection was 1.5% (95%CI 1.4–1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality wasincreased in patients having surgery within 0–2 weeks, 3–4 weeks and 5–6 weeks of the diagnosis (odds ratio(95%CI) 4.1 (3.3–4.8), 3.9 (2.6–5.1) and 3.6 (2.0–5.2), respectively). Surgery performed≥7 weeks after SARS-CoV-2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95%CI) 1.5 (0.9–2.1)). After a≥7 week delay in undertaking surgery following SARS-CoV-2 infection, patients with ongoing symptoms had ahigher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0% (95%CI 3.2–8.7) vs. 2.4% (95%CI 1.4–3.4) vs. 1.3% (95%CI 0.6–2.0), respectively). Where possible, surgery should be delayedfor at least 7 weeks following SARS-CoV-2 infection. Patients with ongoing symptoms≥7 weeks from diagnosismay benefit from further dela</dc:description>
<dc:date>2024-02-06T10:09:43Z</dc:date>
<dc:date>2024-02-06T10:09:43Z</dc:date>
<dc:date>2021</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>Collaborative, G., &amp; COVIDSurg Collaborative. (2021). Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study. Anaesthesia, 76(6), 748. https://doi.org/10.1111/anae.15458</dc:identifier>
<dc:identifier>0003-2409</dc:identifier>
<dc:identifier>http://hdl.handle.net/10366/155372</dc:identifier>
<dc:identifier>10.1111/anae.15458</dc:identifier>
<dc:identifier>1365-2044</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>https://doi.org/10.1111/anae.15458</dc:relation>
<dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
<dc:publisher>Wiley&amp;Sons</dc:publisher>
</ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>